Aliases & Classifications for Vulvitis

MalaCards integrated aliases for Vulvitis:

Name: Vulvitis 12 41 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:3901
ICD10 32 N76.2
MeSH 41 D014847
UMLS 69 C0042996

Summaries for Vulvitis

MalaCards based summary : Vulvitis is related to salpingitis and de quervain disease, and has symptoms including pruritus vulvae An important gene associated with Vulvitis is NXN (Nucleoredoxin), and among its related pathways/superpathways are NF-kappaB Signaling and B Cell Development Pathways. The drugs Acetylcholine and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include testes and colon.

Wikipedia : 72 Vulvitis is inflammation of the vulva, the external female mammalian genitalia that include the labia... more...

Related Diseases for Vulvitis

Diseases related to Vulvitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 131)
# Related Disease Score Top Affiliating Genes
1 salpingitis 30.3 CD40LG CD79A
2 de quervain disease 10.5 ELANE MRAP
3 optic papillitis 10.5 CD40LG MRAP
4 selective igg deficiency disease 10.5 CD40LG CD79A
5 c1q nephropathy 10.5 CD40LG CD79A
6 meningovascular neurosyphilis 10.5 CD40LG CD79A
7 alpha chain disease 10.5 CD40LG CD79A
8 brill-zinsser disease 10.5 CD40LG CD79A
9 exudative glomerulonephritis 10.5 CD40LG CD79A
10 cork-handlers' disease 10.5 CD40LG CD79A
11 acute retinal necrosis syndrome 10.5 CD40LG MRAP
12 salpingo-oophoritis 10.5 CD40LG CD79A
13 early yaws 10.5 CD40LG CD79A
14 aortitis 10.5 MPO MRAP
15 ventilation pneumonitis 10.5 CD40LG CD79A
16 chronic interstitial cystitis 10.5 CD40LG CD79A
17 axillary adenitis 10.5 CD40LG CD79A
18 cryofibrinogenemia 10.5 CD40LG CD79A
19 trichostrongyloidiasis 10.5 CD40LG CD79A
20 subacute bacterial endocarditis 10.5 CD40LG CD79A
21 heterophyiasis 10.5 CD40LG CD79A
22 immunoglobulin g deficiency 10.5 CD40LG CD79A
23 orbital granuloma 10.5 CD40LG CD79A
24 transient hypogammaglobulinemia of infancy 10.5 CD40LG CD79A
25 hyperglobulinemic purpura 10.5 CD40LG CD79A
26 gastroduodenitis 10.5 CD40LG CD79A
27 bacterial conjunctivitis 10.5 CD40LG CD79A
28 heavy chain disease 10.5 CD40LG CD79A
29 iritis 10.5 CD40LG MRAP
30 ophthalmia neonatorum 10.5 CD40LG CD79A
31 farmer's lung 10.5 CD79A ELANE
32 immunoglobulin a deficiency 1 10.5 CD40LG CD79A
33 cerebral arteritis 10.5 CD40LG CD79A
34 selective immunoglobulin deficiency disease 10.4 CD40LG CD79A
35 geniculate herpes zoster 10.4 CD40LG CD79A
36 erythema elevatum diutinum 10.4 CD40LG CD79A
37 sporotrichosis 10.4 CD40LG CD79A
38 fallopian tube disease 10.4 CD40LG CD79A
39 hyperimmunoglobulin syndrome 10.4 CD40LG CD79A
40 pasteurellosis 10.4 ELANE MPO
41 congenital syphilis 10.4 CD40LG CD79A
42 mononeuritis multiplex 10.4 CD40LG MPO
43 polyclonal hypergammaglobulinemia 10.4 CD40LG CD79A
44 mononeuritis of upper limb and mononeuritis multiplex 10.4 CD40LG MPO
45 maxillary sinusitis 10.4 CD79A MPO
46 ocular toxoplasmosis 10.4 CD40LG CD79A
47 parasitic ichthyosporea infectious disease 10.4 CD40LG CD79A
48 dysgammaglobulinemia 10.4 CD40LG CD79A
49 congenital hypogammaglobulinemia 10.4 CD40LG CD79A
50 acute maxillary sinusitis 10.4 CD40LG CD79A

Graphical network of the top 20 diseases related to Vulvitis:



Diseases related to Vulvitis

Symptoms & Phenotypes for Vulvitis

UMLS symptoms related to Vulvitis:


pruritus vulvae

Drugs & Therapeutics for Vulvitis

Drugs for Vulvitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 88)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcholine Approved Phase 4,Phase 3 51-84-3 187
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
3
Fluconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 86386-73-4 3365
4
Clotrimazole Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 23593-75-1 2812
5
Dequalinium Approved, Investigational Phase 4 6707-58-0
6
Terconazole Approved Phase 4 67915-31-5 441383
7
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 1 137-58-6 3676
8 abobotulinumtoxinA Phase 4,Phase 3
9 Botulinum Toxins Phase 4,Phase 3
10 Botulinum Toxins, Type A Phase 4,Phase 3
11 Cholinergic Agents Phase 4,Phase 3
12 Neurotransmitter Agents Phase 4,Phase 3
13 onabotulinumtoxinA Phase 4,Phase 3
14 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
15 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
16 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
17 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
18 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
19 Hormones Phase 4,Phase 3,Phase 2,Phase 1
20 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
21 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
22 Anti-Infective Agents, Local Phase 4,Phase 3
23 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3
24 Anesthetics Phase 4,Phase 2,Phase 1
25 Anesthetics, Local Phase 4,Phase 2,Phase 1
26 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 1
27 Central Nervous System Depressants Phase 4,Phase 2,Phase 1
28 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 1
29 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Sodium Channel Blockers Phase 4,Phase 2,Phase 1
31
Nifedipine Approved Phase 3 21829-25-4 4485
32
Milnacipran Approved, Investigational Phase 3 92623-85-3 65833
33
Butoconazole Approved Phase 3 64872-76-0, 64872-77-1 47472
34
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
35
Amphotericin B Approved, Investigational Phase 3,Phase 2 1397-89-3 5280965 14956
36
Ketoconazole Approved, Investigational Phase 3 65277-42-1 3823 47576
37
Tetracycline Approved, Vet_approved Phase 3 60-54-8 5353990
38
Capsaicin Approved Phase 2, Phase 3,Phase 1 404-86-4 1548943
39 Tomato Approved, Nutraceutical Phase 3
40 calcium channel blockers Phase 3,Phase 2
41 Calcium, Dietary Phase 3,Phase 2
42 Tocolytic Agents Phase 3
43 Vasodilator Agents Phase 3
44 Adrenergic Agents Phase 3
45 Antidepressive Agents Phase 3
46 Neurotransmitter Uptake Inhibitors Phase 3
47 Psychotropic Drugs Phase 3,Phase 2
48
Serotonin Phase 3 50-67-9 5202
49 Serotonin Agents Phase 3
50 Serotonin Uptake Inhibitors Phase 3

Interventional clinical trials:

(show top 50) (show all 82)

# Name Status NCT ID Phase Drugs
1 Botox on Vulvar Vestibulitis Unknown status NCT00119886 Phase 4 Botulinum toxin
2 Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Completed NCT02248506 Phase 4
3 Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis Completed NCT02242695 Phase 4 Fluomizin vaginal tablets;Canesten vaginal tablets
4 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Completed NCT02180828 Phase 4 Clotrimazole vaginal tablet;Fluconazole
5 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Completed NCT02180100 Phase 4 Terconazole Vaginal Suppository;Fluconazole
6 Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina Completed NCT00194324 Phase 4 Miconazole nitrate
7 Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia Recruiting NCT01935063 Phase 4
8 Dysbiosis in Localized Provoked Vulvodynia (LPV) Unknown status NCT02393911 Phase 3
9 Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis Completed NCT00496184 Phase 3 Nifedipine cream topical application
10 Savella in Treatment for Provoked Vestibulodynia Completed NCT01304589 Phase 3 Milnacipran
11 Vaginal Infection Study Completed NCT00616330 Phase 3 clindamycin phosphate/butoconazole nitrate;clindamycin phosphate;butoconazole nitrate
12 Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis Completed NCT02251093 Phase 3 Lcr Regenerans;Placebo
13 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed NCT01806623 Phase 3 Fluconazole
14 A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) Completed NCT01293643 Phase 3 100 mg clindamycin /800 mg ketoconazole vaginal ovule;100 mg tetracycline hydrochloride /50 mg amphotericin B cream
15 Comparative Efficacy of Ovule vs Tablet Completed NCT00755053 Phase 3 Clotrimazole, vaginal ovule;Clotrimazole, vaginal tablet
16 Diabetes Mellitus and Vulvovaginal Candidiasis Completed NCT00353561 Phase 3 Boric;Fluconazole
17 A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia Recruiting NCT02858219 Phase 3 Botulinum Toxin Type A
18 A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia Recruiting NCT02854670 Phase 2, Phase 3 Capsaicin patch
19 ProF-001_Phase IIa Recruiting NCT03115073 Phase 2, Phase 3 Candiplus;Clotrimazole
20 Botulinum Toxin A as a Treatment for Provoked Vestibulodynia Not yet recruiting NCT02773641 Phase 3 Botulinum Toxin Type A;Placebo
21 Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Cream. Not yet recruiting NCT03005353 Phase 2, Phase 3 Cumin seed extract;clotrimazole
22 Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis Not yet recruiting NCT02907307 Phase 3 Clotrimazole vaginal tablet 100mg
23 Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis Completed NCT00004316 Phase 1, Phase 2 capsaicin
24 Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Completed NCT02971007 Phase 2 Oral Encochleated Amphotericin B (CAMB);Fluconazole
25 RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections Completed NCT02733432 Phase 2 CD101 Vaginal Gel (3%);CD101 External gel (1%);CD101 Vaginal Ointment (6%);CD101 External ointment (1%);Fluconazole
26 TOL-463 Phase 2 Study for Vaginitis Completed NCT02866227 Phase 2 TOL-463;TOL-463
27 Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis Completed NCT02679456 Phase 2 SCY-078;Fluconazole
28 A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Completed NCT02267382 Phase 2 VT-1161;Placebo
29 Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis Completed NCT01926028 Phase 1, Phase 2
30 A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Acute Vaginal Candidiasis (Yeast Infection) Completed NCT01891331 Phase 2 VT-1161 (oral);Fluconazole (oral)
31 MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis Completed NCT01497223 Phase 2 MGCD290
32 Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment Completed NCT01144286 Phase 2 arasertaconazole nitrate;placebo
33 An Active-Controlled, Dose-Finding Study of SCY-078 vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis Recruiting NCT03253094 Phase 2 Fluconazole;SCY-078
34 Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis Not yet recruiting NCT03167957 Phase 2 Oral Encochleated Amphotericin B (CAMB);Oral Encochleated Amphotericin B (CAMB)
35 Patients With Vulvovaginal Candidiasis Not yet recruiting NCT03024502 Phase 1, Phase 2 EPP-AF Gel 1%;EPP-AF Gel 2%;Clotrimazole
36 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis Terminated NCT00450242 Phase 2 5% topical lidocaine ointment;Placebo cream
37 Pregabalin for the Treatment of Vulvodynia Terminated NCT00853229 Phase 2 pregabalin
38 Efficacy Vulvovaginitis Candida Terminated NCT00199264 Phase 2 Albaconazole oral solution
39 Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis Unknown status NCT00479947 Phase 1 Probiotics (Natural product);Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14)
40 Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study Completed NCT01996384 Phase 1 Lidocaine
41 Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation Completed NCT02730494 Phase 1
42 Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection Completed NCT01067131 Phase 1
43 Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine Completed NCT00276068 topical lidocaine + oral desipramine, and/or placebo
44 Long-Term Assessment of Quality of Life and Effectiveness of Onabotulinumtoxina Injections in Provoked Vestibulodynia Completed NCT02858375
45 Efficacy of Transcranial Direct-Current Stimulation (tDCS) for Provoked Vestibulodynia : a Triple Blind Randomized Controlled Trial Completed NCT02543593
46 Effectiveness of Cognitive Behavioural Therapy and Physical Therapy for Provoked Vestibulodynia Completed NCT02494934
47 The Use of Acupuncture for the Treatment of Vulvar Vestibulitis Completed NCT02362763
48 "Vestibulitis Educational Seminar Trial" Study Completed NCT00278850
49 Pregnancy, Childbirth Intentions and Outcomes Under Sexual Pain Completed NCT01731288
50 Integrated Mindfulness-based Cognitive Behaviour Therapy Versus Cognitive Behaviour Therapy for Provoked Vestibulodynia Completed NCT01704456

Search NIH Clinical Center for Vulvitis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: vulvitis

Genetic Tests for Vulvitis

Anatomical Context for Vulvitis

MalaCards organs/tissues related to Vulvitis:

38
Testes, Colon

Publications for Vulvitis

Articles related to Vulvitis:

(show top 50) (show all 125)
# Title Authors Year
1
Zoon Vulvitis Treated Successfully With Platelet-Rich Plasma: First Case Reported. ( 28857965 )
2017
2
Zoon vulvitis. ( 29267481 )
2017
3
Successful treatment of intractable vulvitis circumscripta plasmacellularis via combination therapy with topical tacrolimus and tetracycline. ( 27786391 )
2016
4
Case 4: Vulvitis in a nonsexually active adolescent girl. ( 26941554 )
2016
5
Symptoms in plasma cell vulvitis: first observational cohort study on type, frequency and severity. ( 25633048 )
2015
6
Plasma cell vulvitis. ( 26692614 )
2015
7
Comparative study on topical immunomodulatory and anti-inflammatory treatments for plasma cell vulvitis: long-term efficacy and safety. ( 25059818 )
2014
8
Granulomatous cheilitis with granulomatous vulvitis: a rare association. ( 24177613 )
2013
9
Longstanding Crohn's vulvitis successfully treated with combined anti-TNFI+ antibody and azathioprine. ( 23815219 )
2013
10
Zoon vulvitis as a differential diagnosis in an HIV-infected patient: a short report. ( 23449712 )
2013
11
Vulvitis granulomatosa, Melkersson-Rosenthal syndrome, and Crohn's disease: dramatic response to infliximab therapy. ( 22788815 )
2012
12
Plasma cell vulvitis: a vulvar itching dilemma. ( 22421677 )
2012
13
Asymptomatic granulomatous vulvitis and granulomatous cheilitis in childhood: the need for Crohn disease workup. ( 21694543 )
2011
14
Clinical effectiveness of a special silk textile in the treatment of recurrent pediatric inflammatory vulvitis: an open label pilot study. ( 21956267 )
2011
15
Diagnosis and treatment of Zoon's vulvitis. ( 21823840 )
2011
16
Vulvitis plasmacellularis circumscripta in pre-existing lichen sclerosus: treatment with imiquimod 5% cream. ( 20542167 )
2010
17
Chronic vulvitis in pre-pubertal girls. ( 20546218 )
2010
18
Zoon's vulvitis (vulvitis circumscripta plasmacellularis). ( 20333391 )
2010
19
Case series of Zoon vulvitis. ( 20040837 )
2010
20
Idiopathic pustular vulvitis. ( 19778311 )
2009
21
Tacrolimus 0.1% ointment: is it really effective in plasma cell vulvitis? Report of four cases. ( 18182819 )
2008
22
Ulcerative vulvitis and balanitis in sheep flocks. ( 18641377 )
2008
23
'HPV vulvitis' revisited: frequent and persistent detection of novel epidermodysplasia verruciformis-associated HPV genotypes. ( 18251739 )
2008
24
Extensive mucinous metaplasia of the vulva arising within Zoon's vulvitis. ( 17263821 )
2007
25
Contact vulvitis due to Pseudowintera Colorata in a topical herbal medicament. ( 17340033 )
2007
26
A case of idiopathic granulomatous cheilitis and vulvitis. ( 17614801 )
2007
27
Successful treatment of Zoon's vulvitis with high potency topical steroid. ( 15834511 )
2006
28
Vulvitis circumscripta plasmacellularis: success with a modified treatment regimen using imiquimod. ( 16390720 )
2006
29
Imiquimod treatment of vulvitis circumscripta plasmacellularis. ( 16777111 )
2006
30
Retrospective histopathologic reevaluation of 18 cases of plasma cell vulvitis. ( 15730165 )
2005
31
Ulcerative balanitis and vulvitis of Dorper sheep in South Africa: a study on its aetiology and clinical features. ( 16642715 )
2005
32
Plasma cell vulvitis: a rare cause of intractable vulvar pruritus. ( 15967935 )
2005
33
A case of vulvitis granulomatosa. ( 16361737 )
2005
34
Topical misoprostol therapy for plasma cell vulvitis: a case series. ( 16044059 )
2005
35
In vitro antimicrobial susceptibility of Mycoplasma mycoides mycoides large colony and Arcanobacterium pyogenes isolated from clinical cases of ulcerative balanitis and vulvitis in Dorper sheep in South Africa. ( 16642716 )
2005
36
Apareunia in a patient with Zoon's vulvitis. ( 16147756 )
2005
37
Idiopathic granulomatous vulvitis. ( 15250899 )
2004
38
Are patch tests useful in plasma cell vulvitis? ( 15018438 )
2004
39
Squamous cell carcinoma of the bladder presenting as vulvitis and cliteromegaly. ( 15581990 )
2004
40
Vulvitis granulomatosa and unilateral hypertrophy of the vulva related to Crohn's disease: a case report. ( 15547549 )
2004
41
Ulcerative vulvitis circumscripta plasmacellularis. ( 14986474 )
2004
42
Plasma cell vulvitis and response to topical steroids: a case report. ( 12935388 )
2003
43
Ulcerative vulvitis in atypical Reiter's syndrome. ( 12664030 )
2003
44
Chronic vulvar purpura: persistent pigmented purpuric dermatitis (lichen aureus) of the vulva or plasma cell (Zoon's) vulvitis? ( 14507407 )
2003
45
Resolution of vulvitis circumscripta plasmacellularis with topical imiquimod: two case reports. ( 14511002 )
2003
46
Retrospective study of proliferative papillary vulvitis in Florida panthers. ( 11838202 )
2002
47
Re: K. Reddy et al.'s case report on a rare case of plasma cell vulvitis (Zoon's vulvitis). ( 12528723 )
2002
48
Vulvitis attributed to hypersensitivity to estrogen. A report of 11 cases. ( 10900584 )
2000
49
Vulvitis circumscripta plasmacellularis mimicking child abuse. ( 10827417 )
2000
50
Fungal culture findings in cyclic vulvitis. ( 10908782 )
2000

Variations for Vulvitis

Expression for Vulvitis

Search GEO for disease gene expression data for Vulvitis.

Pathways for Vulvitis

Pathways related to Vulvitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.77 CD40LG CD79A MPO TNFRSF8
2 10.52 CD40LG CR2 TNFRSF8

GO Terms for Vulvitis

Biological processes related to Vulvitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 B cell differentiation GO:0030183 9.33 CD40LG CD79A CR2
2 negative regulation of growth of symbiont in host GO:0044130 9.26 ELANE MPO
3 response to yeast GO:0001878 8.96 ELANE MPO
4 B cell proliferation GO:0042100 8.8 CD40LG CD79A CR2

Sources for Vulvitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....